In Cal-27 and SCC4/9 cells derived oral squamous cell carcinoma, ECGC, and a MAPK-pathway inhibitor PD98059 diminished MMP2 activity and invasion/migration of these cells. This evidence concerns the gene MMP2 and oral cavity squamous cell carcinoma.